Dr David Paul Sniezek, DC, MD, FAAIM in Washington, DC - Medicare Physical Medicine And Rehabilitation Provider

Dr David Paul Sniezek, DC, MD, FAAIM is a medicare enrolled "Physical Medicine & Rehabilitation" provider in Washington, District Of Columbia. He graduated from medical school in 1983 and has 41 years of diverse experience with area of expertise as Physical Medicine And Rehabilitation. His current practice location is 908 New Hampshire Ave Nw, #500, Washington, District Of Columbia. You can reach out to his office (for appointments etc.) via phone at (202) 296-3555.

Dr David Paul Sniezek is licensed to practice in Virginia (license number 44421) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1164537130.

Contact Information

	Dr David Paul Sniezek, DC, MD, FAAIM
	908 New Hampshire Ave Nw, #500, Washington, DC 20037-2346
	(202) 296-3555
	(202) 296-0214

Healthcare Provider's Profile

Full Name	Dr David Paul Sniezek
Gender	Male
Speciality	Physical Medicine And Rehabilitation
Experience	41 Years
Location	908 New Hampshire Ave Nw, Washington, District Of Columbia
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr David Paul Sniezek graduated from medical school in 1983

NPI Data:

NPI Number: 1164537130
Provider Enumeration Date: 08/20/2006
Last Update Date: 05/16/2019

Medicare PECOS Information:

PECOS PAC ID: 2567511652
Enrollment ID: I20090520000203

Medical Identifiers

Medical identifiers for Dr David Paul Sniezek such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164537130	NPI	-	NPPES
14170001	Other	DC	BLUECROSS BLUESHIELD
028403700	Medicaid	DC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
111N00000X	Chiropractor	0104000271 (Virginia)	Secondary
111N00000X	Chiropractor	CH30035 (District Of Columbia)	Secondary
171100000X	Acupuncturist	(District Of Columbia)	Secondary
171100000X	Acupuncturist	(Virginia)	Secondary
208100000X	Physical Medicine & Rehabilitation	17362 (District Of Columbia)	Secondary
208100000X	Physical Medicine & Rehabilitation	44421 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David Paul Sniezek is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr David Paul Sniezek, DC, MD, FAAIM 908 New Hampshire Ave Nw Ste 500, Washington, DC 20037-2352 Ph: (202) 296-3555	Dr David Paul Sniezek, DC, MD, FAAIM 908 New Hampshire Ave Nw, #500, Washington, DC 20037-2346 Ph: (202) 296-3555

News Archive

Vaccines for alcoholism and cocaine addiction coming soon

In a latest development, researchers from Chile have come up with a vaccine to cure alcoholics. It will help them kick the habit by creating a sensation of a terrible hangover after just a few drinks. The mechanism by which this vaccine acts is by neutralizing a group of enzymes that help the body to break down alcohol. When the enzymes aldehyde dehydrogenase is disabled the body accumulates the alcohol to create the hangovers after just a few drinks.

Impaired blood clot contraction predicts imminent postoperative thrombosis

The co-authors are employees of the Protein-Cell Interactions Lab of Kazan Federal University (Natalia G. Evtugina, Alina D. Peshkova, and Lab Head Rustem I. Litvinov) in cooperation with Interregional Clinical Diagnostic Center, Kazan, Russia (Arseniy A. Pichugin) and University of Pennsylvania (John W. Weisel and Rustem I. Litvinov by his primary employment).

Potential malaria transmission-blocking vaccine

Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human primates for use in a potential transmission-blocking vaccine.

Leukaemia patients could safely reduce side effects of drug by cutting dose in half, study shows

Patients with a chronic type of leukaemia could safely reduce the side effects of life-long treatment by cutting their dose in half, according to the results of a University of Liverpool led study presented at an international conference in America this week.

Dr David Paul Sniezek, DC, MD, FAAIM - Medicare in Washington, DC